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Abstract 
Objectives: To present an overview of the management strategies of dentin 
hypersensitivity (DHS) and so summarize and discuss the therapeutic options. 
Materials and Methods: A PUBMED literature search was conducted to identify 
articles dealing with dentin hypersensitivity prophylaxis and treatment. We focussed 
on meta-analyses where available or controlled clinical trials.  
Results: DHS therapy should start with non-invasive individual prophylactic home-
care approaches. In-office therapy follows with nerve desensitizing, precipitating or 
plugging agents. If the hypersensitivity persists, depending on the hard and soft 
tissue components at re-evaluation, i.e. presence or absence of cervical lesions and 
the gingival contour, adhesive restorations including sealing or muco-gingival surgery 
may be an option. They allow for the establishment of a physico-mechanical barrier. 
As the placebo effect may play an important role, adequate patient management 
strategies and positive reinforcement may improve the management of DHS in the 
future.  
Conclusions: Life-long maintenance under the premise of strict control of the 
causative factors is crucial in the management of DHS.  
Clinical relevance: Clinicians are faced with a broad spectrum of therapeutic options. 
Therapy should not only focus on pain reduction or better elimination, but also on the 
modification of the exposed cervical dentin area based on the defect type. 
 
Keywords: Dentin hypersensitivity; therapy; review 
 
  
Background and aim 
Dentin hypersensitivity (DHS) describes a painful symptom of the exposed and 
innervated cervical pulp-dentin complex. Its prevalence greatly varies and ranges 
from 3 up to 98% and can be explained – in part - by different evaluation methods 
and different patient populations e.g. patients suffering from periodontitis [1].  
It is important to acknowledge that localized attachment loss is probably the most 
widespread and relevant factor leading to any root surface denudation and dental 
hard tissue sequelae, including DHS. Several predisposing factors of gingival 
recessions have been identified, e.g. dehiscency or fenestration of the alveolar bone 
and soft tissue morphotype, but triggering pathological, therapeutic or iatrogenic 
factors are also crucial for its development [2, 3]. Loss of dental hard tissue in the 
coronal aspect, especially enamel, is considered an alternative pathway of cervical 
dentin exposure and is mainly caused by erosion, abrasion and abfraction or a 
combination thereof [2, 3].  
DHS is mainly a diagnosis of exclusion. Thus, differential diagnostic aspects play a 
pivotal role and a thorough anamnestic evaluation is indispensable to identify 
etiopathgenic factors [4]. This decision process is important to effectively control and 
treat underlying causative and modifying factors [5]. 
Different materials and methods have been described to treat DHS. Cause-related 
therapy primarily aims to mechanically or chemically protect the pulp-dentin complex 
or to suppress or modify the nerve stimulation while controlling the predisposing 
factors. However, no treatment has been found so far, which could serve as a 
defined therapeutical gold standard, which predictably and completely eliminates 
pain perception, especially in the long-term. Root canal therapy may be considered 
as the last resort, but there is consensus that this invasive treatment should not be 
considered in the first line. In contrast, treatment should conceptually start with 
minimally invasive and reversible approaches. If these are not successful at re-
evaluation, subsequently more invasive, and maybe more expensive or even 
irreversibe treatment options, should be envisioned. A crucial question is whether or 
when does treatment becomes necessary. Table 1 gives an overview of a suggested 
decision tree for intervention and additional differential diagnosis.  
If a patient self-reports pain, the necessity of DHS treatment is evident. A pain 
provocation test should then be performed. Most commonly, air application and/or 
gentle scratching with a probe are used for this purpose. If this pain provocation test 
is positive and other pathologies can be excluded (differential diagnosis), DHS 
therapy should be initiated. In the case of a negative provocation test, special 
emphasis should be put on the differential diagnosis and the cause of the pain should 
be carefully evaluated (endodontic or cariologic origin, orofacial pain etc.). If a patient 
reports no hypersensitive episodes, a provocation test is optional but recommended 
during routine dental screening. In the case of exposed cervical areas which are 
sensitive upon provocation, a treatment can be considered in prophylactic terms. In 
case of a negative provocation test, any DHS therapy becomes needless. It is 
important to acknowledge that not all patients report hypersensitivity experiences, 
and dentists and prophylaxis personnel should therefore screen for DHS on a routine 
basis. 
This article focuses on the current management of DHS. Different materials and 
techniques are critically discussed and future perspectives are shown. Whenever 
possible, systematic reviews were used to document the success/failure of a method.  
 
 
 
Current management of DHS 
Prevention is better than cure. Thus, primary prevention of dentin exposure as a 
result of recession formation and/or dental hard tissue damage by any prophylactic 
measures or erosive/abrasive diet is the best way to actually treat this phenomenon 
and its associated painful symptoms [6]. Special focus must thus be set on the 
prevention of DHS, such as to avoid erosive drinks or foods, and choose non-
abrasive toothbrushes, brushing techniques, etc. 
The management of DHS can be generally divided in two different approaches: Self-
performed therapy at home (professionally dispensed self-applied or over the 
counter), or in-office treatment. The latter normally applies more sophisticated non-
invasive or invasive methods using professional materials and techniques. In 
general, all interventions should start with non-invasive, reversible, non-hazardous, 
easy to perform and inexpensive options. Only if they prove to be ineffective at re-
evaluation, should more invasive interventions be considered. 
Conceptually, treatment of DHS aims either to suppress the nerve impulse by direct 
neurological interaction or by mechanical blockage of the tubules.  
Potassium ions can decrease the excitability of A-fibers, which surround the 
odontoblasts, thus resulting in a significant reduction in tooth sensitivity. Toothpastes 
for instance contain mostly 5% potassium nitrate [7], but there is still a debate 
concerning its effectiveness [8].  
Aside from nerve desensitation, occlusion of the dentinal tubules is the main 
therapeutic approach (Fig. 1). There is a plethora of agents, materials and products 
available on the market for this purpose. Different mechanisms can be identified to 
modify the dentin surface or tubules by chemical, mechanical and/or physical means, 
e.g. protein precipitation, plugging of dentin tubules, sealing or laser applications. 
Aquous glutaraldehyde containing solutions have shown to be effective in reducing 
dentin hypersensitivity [9]. They have been shown to close dentinal tubules by 
precipitative intratubular occlusion and thereby to a significant decrease of dentin 
permeability, even under clinical conditions [10, 11].  As a positive side effect, 
glutaraldehyde disinfects dentin in vitro and seems compatible with adhesive 
systems [12, 13]. However, potential biocompatibility hazards should not be 
neglected [14, 15].  
Different plugging agents have been described and most products belong to this 
group of action. Among these, oxalates have been used to precipitate and occlude 
the tubules. However, a systematic review recently revealed that with the possible 
exception of 3% monohydrogen monopotassium oxalate, available evidence does 
not currently support the recommendation of dentin hypersensitivity treatment with 
oxalates [16].  
Products containing arginine/calcium carbonate, bioactive glass or strontium acetate 
have been introduced in the market with similar modes of action (occlusion of the 
tubule openings) and seem to provide good clinical results and pain relief [17-19]. 
The available home-care products should be considered as a first approach. 
Fluoride varnishes have also shown to protect the dentin surface by forming a 
protective layer of calcium fluoride [20-22]. Whereas lasers have been frequently 
assessed in the management of DHS, their clinical success is questionable [23]. 
However, fluoride gels in combination with laser showed some cumulative efficacy 
[24]. Another more exotic approach is the combination of acidulated fluoride gels with 
iontopheresis [25]. 
A reliable technique to close dentin tubules is the application of a chemomechanical 
barrier between the dentin and the oral environment based on adhesive bonding 
techniques [26]. However, most of the bonding agents have no fillers, which 
potentially leads to wear in exposed areas [27]. The question is therefore, how 
effectively can these lesions be re-sealed.  
All methods described above are indicated especially in cases with limited amounts 
of dental hard tissue loss, i.e. no classical abrasive or erosive defect characteristics. 
In cases where a class V filling is indicated, an adhesive filling is a valid option. 
Regenerative mucogingival therapy also remains an alternative, where hard and soft 
tissue conditions allow [28] (Fig. 2). A suggested strategy for DHS management, 
taking these morphological aspects into consideration, is depicted in Figure 3. It 
should be noted that adequate diagnosis and prophylactic measures are a 
prerequisite for any successful management strategy, which is complemented with a 
strict long-term maintenance program in harmony with the special needs of DHS.  
 
Outlook  
DHS still is an underestimated problem in daily clinical practice. Most patients 
develop coping strategies. However, especially in cases where we are confronted 
with moderately symptomatic and more severe episodes, finding the right solution is 
difficult, and trial and error strategies are still a daily occurrence. Thus, the 
development of new materials and methods is greatly needed; including the 
development of improved precipitating materials, which effectively bind to the 
exposed dentin wound and reduce the outflow of dentinal fluid. This outflow 
continues to hamper precipitation or bonding processes. The use of lasers in 
combination with such materials could be beneficial, leading to better precipitation or 
controlled melting mechanisms and impregnation.  
In addition, as we are dealing with exposed cervical dental hard tissue areas, a focus 
also has to be put on improving the caries-resistance of these involved surfaces. The 
development of prophylactic measures with less risk of recession formation or 
abrasion is also warranted.  
Another aspect is the placebo effect, which is an important and potentially beneficial 
side-effect when dealing with pain, and its treatment and management. Using arthritis 
of the knee as an example in the medical field: It has been impressively shown that 
sham endoscopic interventions lead to the same reduction of pain and symptoms as 
conventional treatment modalities [29]. In addition, prescription of differently colored 
pills resulted in significant differences in pain reduction [30]. Whereas a red placebo 
tablet, for instance, showed comparable pain relief as the best antirheumatic test pill 
used, the blue equivalent showed the least effect. Thus, improved psychological co-
therapeutic strategies may one day become an important auxillary aspect in DHS 
management, especially when it comes to changing patients’ expectations of 
treatment outcomes and confidence. The psychological training of dental 
professionals still has some room for development. 
 
Conclusion 
DHS is a problem. While there is not necessarily an acute pathological risk for the 
affected tooth site at the moment, patients may suffer greatly and future damage due 
to the persisting pain challenge and its causative factors, i.e. the co-etiopathological 
factors, cannot be excluded. Therefore, a therapy should not only focus on pain 
reduction or better elimination, but also on the modification of the exposed cervical 
dentin area based on the defect type. Preventive, restorative and periodontal options 
may be individually indicated to resolve the pain problem, while concomitantly 
reducing the risk for future damage to the pulp-dentin complex. Adequate home-care 
products are advisable. 
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